fig1

Extracellular vesicles and miRNA-based therapies in triple-negative breast cancer: advances and clinical perspectives

Figure 1. Quantitative breakdown of topics in reviewed studies on MSC-derived EV therapy. Quantitative analysis of the systematic review by Mizenko et al. (2024) involving clinical trials related to EVs and cited in this article[126]. Analysis of the distribution of prevalent topics in the studies, such as diagnosis, complementary diagnosis, and therapeutic, as well as the main sources of MSC-derived EVs used. Graph Pad Prism 8.0.2. MSCs: Mesenchymal stem cells; EVs: extracellular vesicles.

Extracellular Vesicles and Circulating Nucleic Acids
ISSN 2767-6641 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/